Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations.

Noetzli M, Guidi M, Ebbing K, Eyer S, Zumbach S, Giannakopoulos P, von Gunten A, Csajka C, Eap CB.

Ther Drug Monit. 2013 Apr;35(2):270-5. doi: 10.1097/FTD.0b013e318282ff02.

PMID:
23503455
2.

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.

Noetzli M, Guidi M, Ebbing K, Eyer S, Wilhelm L, Michon A, Thomazic V, Stancu I, Alnawaqil AM, Bula C, Zumbach S, Gaillard M, Giannakopoulos P, von Gunten A, Csajka C, Eap CB.

Br J Clin Pharmacol. 2014 Jul;78(1):135-44. doi: 10.1111/bcp.12325.

3.

Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study.

Clarke JA, Cutler M, Gong I, Schwarz UI, Freeman D, Dasgupta M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):224-33. doi: 10.1016/j.amjopharm.2011.07.003. Epub 2011 Jul 30.

PMID:
21803659
4.

ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.

Gunes A, Spina E, Dahl ML, Scordo MG.

Ther Drug Monit. 2008 Oct;30(5):628-33. doi: 10.1097/FTD.0b013e3181858ca9.

PMID:
18708991
5.

A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.

Leon Jd, Susce MT, Pan RM, Wedlund PJ, Orrego ML, Diaz FJ.

Pharmacopsychiatry. 2007 May;40(3):93-102.

PMID:
17541883
6.

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.

Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA.

Clin Pharmacol Ther. 2004 Dec;76(6):536-44.

PMID:
15592325
7.

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

Lind AB, Reis M, Bengtsson F, Jonzier-Perey M, Powell Golay K, Ahlner J, Baumann P, Dahl ML.

Clin Pharmacokinet. 2009;48(1):63-70. doi: 10.2165/0003088-200948010-00005.

PMID:
19071885
8.

Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects.

Choong E, Polari A, Kamdem RH, Gervasoni N, Spisla C, Jaquenoud Sirot E, Bickel GG, Bondolfi G, Conus P, Eap CB.

J Clin Psychopharmacol. 2013 Jun;33(3):289-98. doi: 10.1097/JCP.0b013e31828f62cd.

PMID:
23609392
9.

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.

Scordo MG, Spina E, Facciolà G, Avenoso A, Johansson I, Dahl ML.

Psychopharmacology (Berl). 1999 Dec;147(3):300-5.

PMID:
10639689
10.

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.

Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, Bertschy G.

Ther Drug Monit. 2008 Aug;30(4):474-82. doi: 10.1097/FTD.0b013e31817d6f5d.

PMID:
18641553
11.

Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.

Suzuki T, Mihara K, Nakamura A, Kagawa S, Nagai G, Nemoto K, Kondo T.

Ther Drug Monit. 2014 Oct;36(5):651-5. doi: 10.1097/FTD.0000000000000070.

PMID:
24682161
12.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, Blanchard R, Nguyen A, Ullmer L, Hayden J, Lemler S, Weinshilboum RM, Rae JM, Hayes DF, Flockhart DA.

J Natl Cancer Inst. 2005 Jan 5;97(1):30-9.

PMID:
15632378
13.

Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.

Kang RH, Jung SM, Kim KA, Lee DK, Cho HK, Jung BJ, Kim YK, Kim SH, Han C, Lee MS, Park JY.

J Clin Psychopharmacol. 2009 Jun;29(3):272-7. doi: 10.1097/JCP.0b013e3181a289e0.

PMID:
19440082
14.

Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients.

Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H.

Biochem Pharmacol. 2015 Jan 1;93(1):104-9. doi: 10.1016/j.bcp.2014.11.011. Epub 2014 Dec 2.

PMID:
25475885
15.

ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.

Crettol S, Déglon JJ, Besson J, Croquette-Krokar M, Hämmig R, Gothuey I, Monnat M, Eap CB.

Clin Pharmacol Ther. 2006 Dec;80(6):668-81.

PMID:
17178267
16.

CYP2D6*4, CYP3A5*3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people.

Blonk MI, van der Velde N, van den Bemt PM, van Schaik RH, van der Cammen TJ.

Pharm World Sci. 2010 Feb;32(1):26-9. doi: 10.1007/s11096-009-9349-1. Epub 2009 Nov 28.

PMID:
19946748
17.

Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects.

Hu M, Yang YL, Fok BS, Chan SW, Chu TT, Poon EW, Yin OQ, Lee VH, Tomlinson B.

Drug Metabol Drug Interact. 2012 Jan 9;27(1):33-9. doi: 10.1515/dmdi-2011-0032.

PMID:
22718623
18.

Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients.

Bakken GV, Molden E, Hermann M.

Ther Drug Monit. 2015 Apr;37(2):256-61. doi: 10.1097/FTD.0000000000000135.

PMID:
25254417
19.

Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.

Wyen C, Fuhr U, Frank D, Aarnoutse RE, Klaassen T, Lazar A, Seeringer A, Doroshyenko O, Kirchheiner JC, Abdulrazik F, Schmeisser N, Lehmann C, Hein W, Schömig E, Burger DM, Fätkenheuer G, Jetter A.

Clin Pharmacol Ther. 2008 Jul;84(1):75-82. doi: 10.1038/sj.clpt.6100452. Epub 2008 Jan 9.

20.

The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.

van der Weide K, van der Weide J.

J Clin Psychopharmacol. 2015 Jun;35(3):228-36. doi: 10.1097/JCP.0000000000000319.

PMID:
25868121

Supplemental Content

Support Center